Your session is about to expire
← Back to Search
Procedure
Blood Flow Restriction Exercise for Arterial Stiffness
N/A
Recruiting
Research Sponsored by Salisbury University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes after exercise trial.
Awards & highlights
Study Summary
This trial looks at the effects of autoregulated & non-autoregulated blood flow restriction arm curls on arterial stiffness in 20 adults. Tests & exercise will be done to compare physiological changes.
Who is the study for?
This trial is for physically active women aged 18-40 with regular menstrual cycles, who have been weight stable. It's not suitable for those with a history of cardiovascular disease, high blood pressure, extreme obesity (BMI>40), diabetes, recent surgery, sleep apnea, liver or kidney disease, claustrophobia or if pregnant/nursing.Check my eligibility
What is being tested?
The study tests how bicep curls with different levels of blood flow restriction affect arterial stiffness in healthy adults. Participants will try three types of arm exercises: without restriction (control), autoregulated and non-autoregulated BFR using the Delfi Personal Tourniquet Systems.See study design
What are the potential side effects?
While specific side effects are not listed for this exercise-based intervention, participants may experience discomfort from the tourniquet system or muscle fatigue due to the exercise protocol.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 minutes after exercise trial.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes after exercise trial.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Beta-Stiffness Index
Carotid-femoral pulse wave velocity
Trial Design
3Treatment groups
Active Control
Group I: Autoregulated blood flow restrictionActive Control1 Intervention
Autoregulated BFR expands as the muscle progresses into the stretch-shortening cycle.
Group II: Non-autoregulated blood flow restrictionActive Control1 Intervention
Non-autoregulated BFR does not expand as the muscle progresses into the stretch-shortening cycle.
Group III: No blood flow restrictionActive Control1 Intervention
This group serves as the control group for this study
Find a Location
Who is running the clinical trial?
Salisbury UniversityLead Sponsor
3 Previous Clinical Trials
65 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of heart attack, stroke, or other major heart problems. You also have other medical conditions that could impact your health or make it difficult to participate in the study, such as respiratory, endocrine, neurological, or blood disorders.You have diabetes.You have been regularly exercising for more than 6 months.You have a current liver or kidney disease that is actively being treated.You are afraid of being in small or enclosed spaces.You have sleep apnea.You have a genetic condition that causes high cholesterol levels called familial hypercholesterolemia.You cannot take any medications or supplements that may affect the outcome of the study.You have a history of alcohol abuse.
Research Study Groups:
This trial has the following groups:- Group 1: Autoregulated blood flow restriction
- Group 2: Non-autoregulated blood flow restriction
- Group 3: No blood flow restriction
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger